Inpatient statin use predicts improved ischemic stroke discharge disposition
Neurology®, 05/25/2012Flint AC et al.
Statin use is strongly associated with improved discharge disposition after ischemic stroke.
The authors used generalized ordinal logistic regression to analyze discharge disposition among 12,689 patients with ischemic stroke over a 7–year period at 17 hospitals in an integrated care delivery system.
They also analyzed treatment patterns by hospital to control for the possibility of confounding at the individual patient level.
Statin users before and during stroke hospitalization were more likely to have a good discharge outcome (odds ratio [OR] for discharge to home=1.38, 95% confidence interval [CI] 1.25–1.52, p<0.001; OR for discharge to home or institution=2.08, 95% CI 1.72–2.51, p<0.001).
Patients who underwent statin withdrawal were less likely to have a good discharge outcome (OR for discharge to home = 0.77, 95% CI 0.63–0.94, p = 0.012; OR for discharge to home or institution=0.43, 95% CI 0.33–0.55, p<0.001).
In grouped–treatment analysis, an instrumental variable method using treatment patterns by hospital, higher probability of inpatient statin use predicted a higher likelihood of discharge to home (OR =2.56, 95% CI 1.71–3.85, p < 0.001).
In last prior treatment analysis, a novel instrumental variable method, patients with a higher probability of statin use were more likely to have a good discharge outcome (OR for each better level of ordinal discharge outcome=1.19, 95% CI 1.09–1.30, p=0.001).
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.